KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Profit After Tax (2017 - 2025)

Twist Bioscience (TWST) has disclosed Profit After Tax for 6 consecutive years, with -$46.2 million as the latest value for Q3 2023.

  • On a quarterly basis, Profit After Tax rose 9.57% to -$46.2 million in Q3 2023 year-over-year; TTM through Sep 2023 was -$204.6 million, a 6.09% increase, with the full-year FY2025 number at -$77.7 million, up 62.77% from a year prior.
  • Profit After Tax was -$46.2 million for Q3 2023 at Twist Bioscience, up from -$57.4 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$24.3 million in Q3 2020 to a low of -$60.7 million in Q1 2022.
  • A 5-year average of -$42.1 million and a median of -$41.2 million in 2021 define the central range for Profit After Tax.
  • Peak YoY movement for Profit After Tax: crashed 145.76% in 2019, then surged 40.87% in 2020.
  • Twist Bioscience's Profit After Tax stood at -$55.6 million in 2019, then soared by 40.87% to -$32.9 million in 2020, then tumbled by 38.49% to -$45.6 million in 2021, then increased by 8.21% to -$41.8 million in 2022, then fell by 10.52% to -$46.2 million in 2023.
  • Per Business Quant, the three most recent readings for TWST's Profit After Tax are -$46.2 million (Q3 2023), -$57.4 million (Q2 2023), and -$59.2 million (Q1 2023).